WSK-IM05 (4×10^10 vp)
2026-891
Phase 1 mab active
Quick answer
WSK-IM05 (4×10^10 vp) for HPV-positive Oropharyngeal Squamous Cell Carcinoma is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- HPV-positive Oropharyngeal Squamous Cell Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active